Laboratory quality control (QC) strategies in resource-constrained settings in MSF–OCA programs Daniel Orozco, Pamela Hepple, Derryck Klarkowski Laboratory.

Slides:



Advertisements
Similar presentations
CAP/POCT 2003 Carol Riley-Hunte, RRT Senior Education Specialist Bayer HealthCare.
Advertisements

DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
Improving diagnosis TB laboratory strengthening.
Area 4 SHARP Face-to-Face Conference Phenotyping Team – Centerphase Project Assessing the Value of Phenotyping Algorithms June 30, 2011.
RBM Communications Assessment Challenges and Opportunities in Ghana, Mali, Senegal, Tanzania and Uganda.
Comprehensive M&E Systems
Coordinating Center Overview November 18, 2010 SPECIAL DIABETES PROGRAM FOR INDIANS Healthy Heart Project Initiative: Year 1 Meeting 1.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Kelley Bemis Use of automated testing in syphilis diagnosis and its impact on surveillance – Connecticut, 2010 CDC/CSTE Applied Epidemiology Fellowship.
PROCUREMENT IN WORLD BANK INVESTMENT OPERATIONS: STATUS OF THE REFORM March, 2014 Operations Policy and Country Services.
Overview of Cambodia Laboratory System & Organizational work flow Structure Dr. Lek Dysoley CNM 8-12 April, 2013.
Module 10: Understanding Laboratory Data *Image courtesy of: World Lung Foundation.
Laboratory Capacity Building in Africa Tsehaynesh Messele, PhD CEO, ASLM.
Protocol Complexity as a Factor in Vendor Management Compliance Risk
Evaluation Office 1 Evaluating Capacity Development David Todd Senior Evaluation Officer GEF Evaluation Office.
Prevention and improved treatment of communicable diseases (HIV/AIDS and TB), including increasing preparedness for bioterrorism and epidemics Anneli Taal,
Overview of operational research in MSF Myriam Henkens, MD, MPH International Medical Coordinator MSF London 1st of June, 2006.
QUALITY ASSURANCE Reference Intervals Lecture 4. Normal range or Reference interval The term ‘normal range’ is commonly used when referring to the range.
Module 5: Assuring the Quality of HIV Rapid Testing
ASCP & Global Outreach. ASCP would like to thank the following for their support and interest: 2 The Center for Disease Control & Prevention– Central.
RAISING THE BAR Meeting CSA Guidelines And Preparing for Health Canada
Training Seminar on Implementation of Effective Quality Assurance Systems in Romanian Higher Education Institutions April 1-3, 2009 Sinaia Criteria for.
1 Module OVERVIEW OF EXTERNAL QUALITY ASSESSMENT.
NEAR PATIENT TESTING, DAWN UPGRADE AND INTO THE COMMUNITY IN THREE MONTHS NEAR PATIENT TESTING, DAWN UPGRADE AND INTO THE COMMUNITY IN THREE MONTHS Barts.
Evidence and Information for Policy Christopher J.L. Murray Executive Director Evidence and Information for Policy World Health Organization National Capacity.
Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.
PORTFOLIO COMMITTEE 20 OCTOBER 2004 MANAGEMENT OF HIV and AIDS IN THE PUBLIC SERVICE.
RHSC Meeting Kampala, May 2010 Quality for Medicines The Global Fund approach Sophie Logez Manager, QA and Data Quality Pharmaceutical Management.
National Commission for Academic Accreditation & Assessment Developmental Reviews at King Saud University and King Faisal University.
Laboratory QA/QC An Overview.
Good Practice for monitoring plans Viewpoint of a DOE Marco van der Linden, SGS Climate Change Programme
BMTA July 2005: 1 Valid Analytical Measurement Studies of Proficiency Testing scheme performance S Ellison LGC Limited, Teddington The work described in.
Roadmap & Actions Expert Consultation Health in All Policies.
21/4/2008 Evaluation of control measures 1. 21/4/2008 Evaluation of control measures 2 Family and Community Medicine Department.
Training course on the Pharmacovigilance of antiretroviral medicines 23 – 28 November 2009 Rationale, Objectives and Expected Outcomes.
1 This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download, adapt, and distribute this.
Indicators in Malaria Program Phases By Bayo S Fatunmbi [Technical Officer, Monitoring & Evaluation] ERAR-GMS, WHO Cambodia & Dr. Michael Lynch Epidemiologist.
Quality control & Statistics. Definition: it is the science of gathering, analyzing, interpreting and representing data. Example: introduction a new test.
Strengthening of continues medical education system in SRH&R Aigul Azimova Kyrgyz State Medical Institute for Retraining and Continuous Education Bishkek.
Dr Rochelle Adams ACC Project Manager On behalf of the ACC team AWACC November 2015 Health systems Strengthening for Success and Sustainability.
TBS Meeting Geneva, November 2010 Procurement and Supply Management Policies WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies, November.
 Remember Chemistry panel Quality Control:-  In a medical laboratory, it is a statistical process used to monitor and evaluate the analytical process.
Jeroen Van’t Pad Bosch, Technical Director Elizabeth Glaser Pediatric AIDS Foundation, Tanzania EGPAF PROJECT HEART STRENGTHENING HEALTH SYSTEMS THROUGH.
Annual Operational Plan 5 Mid-term (July – December 2009) Progress report Dr S K Sharif Director Public Health & Sanitation.
Data, Surveys and Performance Monitoring by Mr Ben Freyer Deputy Director, Regional Support Services, DWSSC 22 November 2012 Ministry of Agriculture, Water.
Quality Assurance and Quality Control in Longitudinal Studies Coralyn W. Whitney, Bonnie K. Lind, and Patricia W. Wahl Epidemiologic Reviews, 1998, Vol.
Clinical Utility of EQA Dr. Angela Amayo UON27/11/2008.
LABORATORY QUALITY MANAGEMENT AS A KEY COMPONENT OF PATIENT MONITORING: THE NYUMBANI DIAGNOSTIC LABORATORY EXPERIENCE Annie P, Susan W, Tresa P, Lihana.
Assessing Logistics System Supply Chain Management 1.
Training for organisations participating in Peer Review of Paediatric Diabetes.
11 Laboratory Quality Improvement for clinical HIV/AIDS Services in the Uniformed Forces Mwaibako, J, Shija, L; Haverkamp, G; van den Hombergh; Katebalila,
Analysis. Answers. Action. Value of LIMS in Optimizing Quality of Care and Treatment of PLHIV 15 th Annual HuQAS Scientific Conference Kenya.
Cindy Tumbarello, RN, MSN, DHA September 22, 2011.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Diagnostic clinical chemistry
CDC and support for Point of Care Testing Accreditation Muthoni Junghae CDC-Kenya LAUNCH OFF POINT OF CARE TESTING ACCREDITATION PROGRAM PANAFRIC HOTEL-18TH.
External Quality Assessment (Proficiency testing) in Diagnostic (Renal) Histopathology Professor Peter Furness Leicester UK.
Durban, July 20th 2016 Ruggero Giuliani MSF - Mozambique
A Quality Improvement Approach to PMTCT programs in South Africa
QUALITY MANAGEMENT Suzanne Kamel-Mohamed PhD, MBA, MT (ASCP) Associate
Overview of Quality Assurance
TB- HIV Collaborative activities in Romania- may 2006 status
Procurement and Supply Management Policies
11 viii. Develop capacity for signal detection and causality assessment Multi-partner training package on active TB drug safety monitoring and management.
IQA 2018 QA Basics September 11, 2018 Day 1 Workshop 1.
5th DEWG meeting Conclusions
Quality Control Lecture 3
Results of the ESS peer reviews
The STOP TB Strategy – 2009 VISION: A TB-free world
Current status – (1) Achievements Building strong political commitment
Presentation transcript:

Laboratory quality control (QC) strategies in resource-constrained settings in MSF–OCA programs Daniel Orozco, Pamela Hepple, Derryck Klarkowski Laboratory Specialists - MSF OCA

Basic health care laboratories Malaria/TB microscopy

Secondary level labs for TB/ HIV programs

High technology labs MDR - TB program Uzbekistan

Background Pre-2005 quality of lab performance within MSF OCA labs was unknown We identified the need to set up a standardized QC system Goals of the programme – Monitor performance – Identify poor performers – Provide clinical staff with information on the accuracy of laboratory results

Program design - Field/HQ input for practicality QC protocol implemented in 2005 Key element is the central reporting system, which enables effective management Immediate finding: – Wide diversity of performance – Unacceptable number of centers were performing poorly 2005 – 2007: Significant improvement across the lab network Background

Malaria, TB, Kala Azar, Cutaneous Leishmaniasis and HIV applying similar principles We also have a separate QC methodology for Chemistry, Hematology and CD4 testing Scope

QC Methodology

Monthly random selection Based on crosschecking Results are sent to Amsterdam Analyzed using % agreement, false positivity and false negativity

QC Methodology Based on a small sample size –5 weak positives + 5 negatives To limit workload for laboratory staff Limited reference laboratory capacity – The small sample size is compensated for by Targeting weak positives, where errors are most likely to occur 4-month cohort analysis (40 slides)

– % agreement – % false positives/false negatives – Quartile analysis – Compliance The statistical analysis has been validated by WHO (LSHTM). Analysis:

Results Between 2005 – 2007: QC monthly reports for malaria from 70 centres - 33,346 slides Currently, 40 centers centrally reporting (20 countries)

Results: Improvement QC alone does not improve performance, but is part of a package – auditing system: Standard Indicators, Equipment, reagents, Infrastructure,Training, in-situ support Progressively strengthening Quality Assurance (QA). E.g. malaria manual, Standard Indicators Reports (SIR), upgrading QC database software

Improvement Identification of weak performers and corrective action taken Our QC programme created a healthy “competition” by comparing centres against each other, which are working under similar circumstances

Conclusions Sustainable method for resource-constrained settings. Practical and with minimal investment Statistically valid Successful - e.g. for Malaria – Median increased from 90% to 100% –1 st quartile increased from 86% to 97% Supports accuracy of diagnosis and operational research

Demands commitment: from field staff for continuous operation lab specialists for central monitoring by issuing compliance and benchmarking reports Depends upon support from Medical Director, Head PHD and CMTs for its implementation and follow up. Conclusions